Status:
UNKNOWN
LIFT Intervention in Liver Transplant Candidates
Lead Sponsor:
Northwestern University
Conditions:
Frailty
Cirrhosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Frailty is a significant problem in patients undergoing liver transplant and is associated with poor outcomes and survival. Hence, optimizing physical fitness and counteracting frailty is important. H...
Detailed Description
Frailty is defined as a biologic syndrome of decreased physiologic reserve and increased vulnerability to health stressors. The concept of frailty has recently emerged as a critical determinant in the...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of liver cirrhosis being evaluated for liver transplantation in hepatology/transplant evaluation clinic
- English-speaking
- Patients with access to a smart phone (with videoconference capabilities)
- Vulnerable populations: We will include patients who are cognitively impaired due to hepatic encephalopathy and unable to consent for themselves.
Exclusion
- Patients \< 18 years of age
- Patients who require outpatient physical therapy.
- Patients without the ability to consent for themselves or through a medical power of attorney.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04836923
Start Date
October 1 2020
End Date
September 1 2025
Last Update
February 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Medicine
Chicago, Illinois, United States, 60611